Tesamorelin Tesamorelin is an FDAapproved peptide for reducing visceral fat, particularly in HIVassociated lipodystrophy, and has robust clinical evidence behind it: Tesamorelin stimulates growth hormone release more effectively than AOD9604
Long-standing insulin resistance, disrupted appetite signals, or metabolic adaptation can make fat loss difficult even when testosterone levels are well managed [4]
The market is estimated to reach around USD 5.2 billion in 2026 and is projected to attain nearly USD 14.4 billion by 2036
Its best to consult with your provider to ensure a safe and effective treatment plan
Our experience shows that the differences are not subtle
It's no surprise that GLP-1 medications like Ozempic, Wegovy, and Zepbound have become a hot topic, especially among moms eager to shed baby weight